Skip to main content

Nonprofit · EIN 13-3156197

MACULA FOUNDATION INC

Tax-exempt (reinstated) · NEW YORK, NY 10065

Financials

$1.9M$269K2024
Revenue Expenses · by fiscal year end
Financials of MACULA FOUNDATION INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
September 30, 2025990$1,891,816$268,883$1,622,933$16,558,308$94,095$16,464,213
Financial details: 990 for the year ended September 30, 2025

Revenue

Contributions, gifts and grants
$220,862
Program service revenue
$0
Investment income
$1,670,954
Other revenue
$0

Expenses

Grants and similar amounts paid
$10,875
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$3,875
Accounting fees
$32,500
Travel
$102,231
Depreciation
$16,247
Program services (functional)
$42,625
Management and general (functional)
$226,258

Balance sheet and other

Total assets, start of year
$15,156,609
Total assets, end of year
$16,558,308
Total liabilities, end of year
$94,095
Net assets, end of year
$16,464,213
Land, buildings and equipment
$108,667
Publicly traded securities
$15,262,304
Net assets without donor restrictions
$15,533,118
Net assets with donor restrictions
$931,095
Gross receipts
$1,891,816
Employees
1
Volunteers
7
Year formed
1983
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended September 30, 2025, highest compensation first.

NameTitleHours / weekCompensation
DR LAWRENCE A YANNUZZICHAIRMAN/PRESIDENT
Trustee or director, Officer
4$0
DR KURT GITTERVICE PRESIDENT
Trustee or director, Officer
1$0
JERRY H LABOWITZTREASURER
Trustee or director, Officer
1$0
MATTHEW TRACHTENBERGDIRECTOR
Trustee or director
1$0
DR JACK DODICKDIRECTOR
Trustee or director
1$0
DR NICHOLAS YANNUZZIDIRECTOR
Trustee or director
1$0

Address and contacts

Address (IRS master file)
210 E 64TH ST, NEW YORK, NY 10065-7471
In care of
% JOAN DALY
Principal officer (990 for 2024)
DR LAWRENCE YANNUZZI, 210 EAST 64TH ST 8TH FL, NEW YORK, NY 10065
Signed the 990
DR LAWRENCE YANNUZZI, CHAIRMAN/PRESIDENT
Phone
(212) 605-3777
Return prepared by
GOLDFINE & CO INC

Mission

TO PREVENT AND RESTORE VISION LOSS BY RAISING AWARENESS ABOUT THE MACULA AND FURTHERING KNOWLEDGE IN THE FIELD WITH INNOVATIVE RESEARCH. BECAUSE OF THE IMPACT ON VISION, OUR PRINCIPAL GOALS HAVE BEEN THE STUDY OF AGE RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND OTHER RETINAL MACULAR DISEASES.

990 for the year ended September 30, 2025

Program accomplishments

  • TO PROVIDE GRANTS AND ALLOCATIONS TO QUALIFIED INSTITUIONS, ORGANIZATIONS AND INDIVIDUALS TO SUPPORT AND PROMOTE RESEARCH ACTIVITIES IN MACULAR ASSOCIATED DISEASES
    Expenses $42,625 · grants $10,876

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in September, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025September 30, 2026February 15, 2027Not due yet
2024September 30, 2025February 16, 2026990 on file
2023September 30, 2024February 17, 2025990 on file

IRS record

EIN
13-3156197
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2024
Accounting year ends
September
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H41)
Assets (IRS master file)
$16,558,308
Income (IRS master file)
$1,891,816

Revocation and reinstatement

Exemption revoked
February 15, 2024
Posted by the IRS
May 15, 2024
Reinstated
Effective February 15, 2024

From the IRS automatic revocation list: organizations that did not file a required return or e-Postcard for three consecutive years.

Filing history

FormYear endedRevenueExpensesAssetsReturn
990September 2025–––IRS
990September 2024–––IRS
990September 2022-$1,951,439$243,468$10,315,605IRS
990September 2020–––IRS
990September 2019–––IRS
990September 2018–––IRS

990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.

Questions about MACULA FOUNDATION INC

What is the EIN of MACULA FOUNDATION INC?
The employer identification number (EIN) of MACULA FOUNDATION INC is 13-3156197.
Is MACULA FOUNDATION INC tax-exempt?
Yes. The IRS revoked its exemption on February 15, 2024 and reinstated it effective February 15, 2024.
Are donations to MACULA FOUNDATION INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does MACULA FOUNDATION INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of MACULA FOUNDATION INC due?
The return for tax year 2025 (the year ending September 30, 2026) is due February 15, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did MACULA FOUNDATION INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended September 2025.
Who is the principal officer of MACULA FOUNDATION INC?
The 990 for the year ended September 30, 2025 names DR LAWRENCE YANNUZZI.
Who are the officers and directors of MACULA FOUNDATION INC?
The 990 for the year ended September 30, 2025 lists 6 people; 0 received compensation from the organization.
How much revenue does MACULA FOUNDATION INC have?
On its 990 for the year ended September 30, 2025 it reported revenue of $1,891,816, expenses of $268,883 and total assets of $16,558,308 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Medical research